Gilotrif
| Gilotrif | |
|---|---|
| Term | Gilotrif |
| Short definition | Gigantism (jy-GAN-tih-zum) A condition in which all or part of the body grows much larger than normal |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Gilotrif - (pronounced) (JEE-loh-trif) A drug used to treat certain types of non-small cell lung cancer that have spread to other parts of the body. It is used in patients whose cancer has not yet been treated and who have certain mutations (changes) in the cancer's EGFR gene, or whose cancer has gotten worse after treatment with platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Gilotrif blocks certain proteins made by the EGFR gene, which can help stop cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Gilotrif is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis drug. Also called afatinib dimaleate
External links
- Medical encyclopedia article on Gilotrif
- Wikipedia's article - Gilotrif
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski